Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COALL 08-09 trial in pediatric acute lymphoblastic leukemia
2009-012758-18Phase 2Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute lymphoblastic leukemia (ALL) comparing Clofarabine + pegaspargase with Historical high-dose cytarabine + pegaspargase comparator (2 arms). Primary endpoints: Primary efficacy and safety endpoint and Safety profile comparison. Started Jan 2010; status: completed.
02
Drugs
clofarabinepegaspargasecytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on 2009-012758-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012758-18.